small molecule

NIFEDIPINE

NIFEDIPINE

Loss of exclusivityloss of exclusivity
CompanySUN PHARMA INDUSTRIES LTD

Drug detail

Brand nameNIFEDIPINE
Active ingredientNIFEDIPINE
Strength30MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalApril 2019
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NIFEDIPINE patent cliff — loss of exclusivity — | CliffBio